டங்கன் பூங்கா ஹோல்டிங்ஸ் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டங்கன் பூங்கா ஹோல்டிங்ஸ் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டங்கன் பூங்கா ஹோல்டிங்ஸ் நிறுவனம் Today - Breaking & Trending Today

Psyched Wellness Ltd.: Psyched Wellness Has Commenced Research on Muscimol for Various Ailments


Psyched Wellness Ltd.: Psyched Wellness Has Commenced Research on Muscimol for Various Ailments
Psyched Wellness Ltd. (
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has commenced research on Muscimol for various ailments, with a focus on mental health issues.
The research is led by Psyched Wellness s board member, Prof. David Nutt. Prof. Nutt is a psychiatrist at the Edmond J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept. of Medicine, Hammersmith Hospital, Imperial College London and is the Chair of the Scientific Advisory Board for COMPASS Pathways. ....

United States , City Of , United Kingdom , David Nutt , Edmondj Safra , Jeffrey Stevens , David Shisel , Wellness Ltd , Newsfile Corp , Neither The Canadian Securities Exchange , Imperial College London , Risk Factors In Psyched Wellness Ltd , Division Of Brain Science , Regulation Services Provider , Duncan Park Holdings Corporation , Psyched Wellness , Brain Science , Hammersmith Hospital , Scientific Advisory Board , Canadian Securities Exchange , Psyched Wellness Ltd , North American , Statement Regarding Forward Looking Information , Toxicology Assessment , Amanita Muscaria , ஒன்றுபட்டது மாநிலங்களில் ,

Psyched Wellness Ltd.: Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria


Psyched Wellness Ltd.: Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (
CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has shipped its first batch of Amanita Muscaria extract to its CRO partner to commence the Pre-Clinical trials.
The Company sent 108 grams of highly concentrated Amanita Muscaria extract to its CRO s lab to begin the first phase of its Pre-Clinical Trial. This first batch of Amanita extract will be used in a study to determine the Maximum Tolerated Dose (MTD). The goal of the study is to determine the highest dose of our extract that will not cause unacceptable side effects or an overt toxicity in a defined period. This is a key first step in determining the appropriate dosage for our future pr ....

United States , Jeff Stevens , Jeffrey Stevens , Risk Factors In Psyched Wellness Ltd , Newsfile Corp , Wellness Ltd , Neither The Canadian Securities Exchange , Natural Health Product Number , Health Canada , Company Or Psyched , Regulation Services Provider , Duncan Park Holdings Corporation , Amanita Muscaria , Maximum Tolerated Dose , Pre Clinical Trials , New Dietary Ingredient , Canadian Securities Exchange , Psyched Wellness Ltd , North American , Statement Regarding Forward Looking Information , Psyched Wellness , Toxicology Assessment , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப் ஸ்டீவன்ஸ் , ஜெஃப்ரி ஸ்டீவன்ஸ் , ஆபத்து காரணிகள் இல் ஆன்மா ஆரோக்கியம் லிமிடெட் ,

Psyched Wellness Ltd.: Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom


Psyched Wellness Ltd.: Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation)
(CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has successfully completed its first extraction of a legal psychedelic derived from Amanita Muscaria mushrooms.
The scientific team sourced dried Amanita Muscaria Mushroom caps from five separate suppliers from different geographic regions around the world. The dried Amanita was extracted using the Company s proprietary extraction protocol and was then packaged and sent with samples of the raw materials to an independent lab. The lab will be testing the extract for the necessary and desired compounds with a goal of providing the Company with a report within 5-7 days. The ....

United States , Jeffrey Stevens , David Shisel , Wellness Ltd , Newsfile Corp , Neither The Canadian Securities Exchange , Risk Factors In Psyched Wellness Ltd , Regulation Services Provider , Company Or Psyched , Duncan Park Holdings Corporation , Amanita Muscaria , Amanita Muscaria Mushroom , Canadian Securities Exchange , Psyched Wellness Ltd , North American , Statement Regarding Forward Looking Information , Psyched Wellness , Toxicology Assessment , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்ரி ஸ்டீவன்ஸ் , ஆரோக்கியம் லிமிடெட் , இல்லை தி கனடியன் பத்திரங்கள் பரிமாற்றம் , ஆபத்து காரணிகள் இல் ஆன்மா ஆரோக்கியம் லிமிடெட் , ஒழுங்குமுறை சேவைகள் வழங்குநர் , நிறுவனம் அல்லது ஆன்மா , டங்கன் பூங்கா ஹோல்டிங்ஸ் நிறுவனம் ,

Psyched Wellness Ltd.: Psyched Wellness Successfully Completes Writing the Final Extraction Protocol, the Assembly of Safety & Efficacy Narratives, and Writing the Safety Data Sheet (SDS) for Its First Product


Psyched Wellness Ltd.: Psyched Wellness Successfully Completes Writing the Final Extraction Protocol, the Assembly of Safety & Efficacy Narratives, and Writing the Safety Data Sheet (SDS) for Its First Product
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation)
(CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the
Company or
Psyched ) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share that it has successfully completed a comprehensive process of lab experiments which have determined the Company s final extraction protocol, that will be used for the company s first line of products.
The company is also pleased to share that it has completed the assembly of the safety and efficacy narratives, and the writing of the safety data sheets (SDS) for its unique Amanita Mascara extract. ....

United States , Jeffrey Stevens , Brian Tancowny , David Shisel , Wellness Ltd , Newsfile Corp , Neither The Canadian Securities Exchange , Risk Factors In Psyched Wellness Ltd , Regulation Services Provider , Company Or Psyched , Duncan Park Holdings Corporation , Amanita Mascara , Head Chemist , Canadian Securities Exchange , Psyched Wellness Ltd , North American , Statement Regarding Forward Looking Information , Psyched Wellness , Toxicology Assessment , Amanita Muscaria , ஒன்றுபட்டது மாநிலங்களில் , ஜெஃப்ரி ஸ்டீவன்ஸ் , ஆரோக்கியம் லிமிடெட் , இல்லை தி கனடியன் பத்திரங்கள் பரிமாற்றம் , ஆபத்து காரணிகள் இல் ஆன்மா ஆரோக்கியம் லிமிடெட் , ஒழுங்குமுறை சேவைகள் வழங்குநர் ,